Search filters

List of works by Annelieke Ecab Willemsen

A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients.

scientific article published on 14 June 2016

Caution for interstitial lung disease as a cause of CA 15-3 rise in advanced breast cancer patients treated with everolimus

scientific article published on 17 January 2014

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

scientific article published on 8 December 2017

Diagnostic challenges of respiratory adverse events during everolimus treatment

scientific article published on 5 March 2014

Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors

scientific article published on 16 March 2016

Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane

scientific article published on 01 October 2018

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

scientific article

Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

scientific article published on 30 August 2010

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations

scientific article published on 27 May 2019

Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma: A Case Report

scientific article published on 28 September 2017

Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid t

scientific article published on 21 January 2016

[Choosing wisely when prescribing statins]

scientific article published in 2015

mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm

scientific article published on 09 October 2015

mTOR inhibitor-related pulmonary toxicity; incidence even higher

scientific article published on 14 February 2013